MCL1 and glioma: Similar detailed biochemical and genetic studies analyzing cellular and molecular responses to RTK inhibition are still pending for glioma cells and derived tumors: Is the Bim/Mcl-1 rheostat important for determining sensitivity of GBM tumors to RTK inhibition?